Clinical Trial Update: A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma [Phase 2]

View source ↗

Summary

This is a Phase 2 study of KC1036 in adolescents with advanced Ewing Sarcoma. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• KC1036

Snippet

Sponsor: Beijing Konruns Pharmaceutical Co., Ltd. | Conditions: Ewing Sarcoma | Phase 2 | Status: RECRUITING